Kaleido Biosciences, Inc. KLDO
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Net Income | -90.29M | -90.03M | -- | -- | -- |
| Total Depreciation and Amortization | 2.36M | 2.32M | -- | -- | -- |
| Total Amortization of Deferred Charges | 705.00K | 787.00K | -- | -- | -- |
| Total Other Non-Cash Items | 10.39M | 11.59M | -- | -- | -- |
| Change in Net Operating Assets | -263.00K | 4.11M | -- | -- | -- |
| Cash from Operations | -77.09M | -71.23M | -- | -- | -- |
| Capital Expenditure | -1.13M | -1.36M | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 438.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -691.00K | -1.36M | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | -- | -- | -- |
| Issuance of Common Stock | 70.40M | 74.12M | -- | -- | -- |
| Repurchase of Common Stock | -339.00K | -309.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -20.00K | -99.00K | -- | -- | -- |
| Cash from Financing | 70.04M | 73.71M | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.75M | 1.13M | -- | -- | -- |